https://research.ssri.co.jp/pmap/pastdata

https://research.ssri.co.jp/pmap/pastdata

1. Nozawa K, Matsuyama S, Higa S, Yamamoto Y, Asami Y. Physician consultation rates and characteristics among workers with chronic pain or headache who participated in a behavioural change program: a retrospective database analysis using real-world healthcare data. BMJ Open. 2022 Nov 10;12(11):e056846.

2. Higa S, Nozawa K, Karasawa Y, Shirai C, Matsuyama S, Yamamoto Y, Laurent T, Asami Y. The Use of a Network Analysis to Identify Associations and Temporal Patterns Among Non-communicable Diseases in Japan Based on a Large Medical Claims Database. Drugs Real World Outcomes. 2022 Sep;9(3):463-476.

3. Shirai C, Matsuoka N, Nakazawa T. Comparison of adherence between fixed and unfixed topical combination glaucoma therapies using Japanese healthcare/pharmacy claims database: A retrospective non-interventional cohort study. BMC ophthalmology. 2021 Dec;21(1):1-2.

4. Osawa I, Goto T, Asami Y, Itoh N, Kaga Y, Yamamoto Y, Tsugawa Y. Physician visits and medication prescriptions for major chronic diseases during the COVID-19 pandemic in Japan: retrospective cohort study. BMJ open. 2021 Jul 1;11(7):e050938.

5. Nozawa K, Higa S, Ii Y, Yamamoto Y, Asami Y. Antidyslipidemic Drug Prescriptions and Lipid Control Status After Unfavorable Annual Health Checkup Results: A Retrospective Cohort Study Using a Health Insurance Database. Drugs-real world outcomes. 2021 Jun;8(2):227-40.

6. Higa S, Ii Y, Nozawa K, Yamamoto Y, Ohwaki K, Asami Y. Relationship of annual health checkups with the subject’s subsequent behavior of cardiovascular risk management in a real-world setting in Japan: a retrospective cohort study on changes in antihypertensive drug prescription and blood pressure from 2015 to 2017. Drugs-real world outcomes. 2021 Jun;8(2):215-25.

7. Osawa I, Goto T, Yamamoto Y, Tsugawa Y. Machine-learning-based prediction models for high-need high-cost patients using nationwide clinical and claims data. NPJ digital medicine. 2020 Nov 11;3(1):1-9.

8. Yuasa A, Murata T, Imai K, Yamamoto Y, Fujimoto Y. Treatment procedures and associated medical costs of methicillin-resistant Staphylococcus aureus infection in Japan: a retrospective analysis using a database of Japanese employment-based health insurance. SAGE open medicine. 2019 Aug;7:2050312119871181.

9. Higa S, Yoshida M, Shima D, Ii Y, Kitazaki S, Yamamoto Y, Fujimoto Y. A Retrospective, Cross-Sectional Study on the Prevalence of Hyperuricemia Using a Japanese Healthcare Database. Arch Rheumatol. 2019 Apr 22;35(1):41-51.

10. Hirano Y, Asami Y, Kuribayashi K, Kitazaki S, Yamamoto Y, Fujimoto Y. Possibility of database research as a means of pharmacovigilance in Japan based on a comparison with sertraline postmarketing surveillance. Value in health regional issues. 2018 May 1;15:1-5.

1. Decker KM, Lambert P, Feely A, Bucher O, Kim JO, Hebbard P, Thiessen M, Fatoye T, Pitz M, Koul R, Czaykowski P. Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba. Curr Oncol. 2021 Aug 12;28(4):3081-3090. 

2. Fakanye O, Singh H, Desautels D, Torabi M. Geographical variation and factors associated with gastric cancer in Manitoba. PLoS One. 2021 Jul 9;16(7):e0253650.

3. Ratnayake I, Park J, Biswanger N, Feely A, Musto G, Decker K. Colorectal Cancer Surgery Quality in Manitoba: A Population-Based Descriptive Analysis. Curr Oncol. 2021 Jun 16;28(3):2239-2247. 

4. Ratnayake I, Hebbard P, Feely A, Biswanger N, Decker K. Assessment of Breast Cancer Surgery in Manitoba: A Descriptive Study [published correction appears in Curr Oncol. 2021 Jul 20;28(4):2775-2777]. Curr Oncol. 2021;28(1):581-592. Published 2021 Jan 19. 

5. Horrill TC, Dahl L, Sanderson E, Munro G, Garson C, Fransoo R, Thompson G, Cook C, Linton J, Schultz ASH. Cancer incidence, stage at diagnosis and outcomes among Manitoba First Nations people living on and off reserve: a retrospective population-based analysis. CMAJ Open. 2019 Dec 18;7(4):E754-E760.

6. Ye X, Mahmud S, Skrabek P, Lix L, Johnston JB. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data. BMJ Open. 2017 Jul 17;7(7):e015106.

7. Dawe DE, Singh H, Wickramasinghe L, Pitz MW, Torabi M. Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba. Can Respir J. 2017;2017:7915905.

8. Lambert P, Galloway K, Altman A, Nachtigal MW, Turner D. Ovarian cancer in Manitoba: trends in incidence and survival, 1992-2011. Curr Oncol. 2017 Apr;24(2):e78-e84.

9. Pruthi DK, Nugent Z, Czaykowski P, Demers AA. Urothelial cancer and the diagnosis of subsequent malignancies. Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E57-64. 

10. Nowatzki J, Moller B, Demers A. Projection of future cancer incidence and new cancer cases in Manitoba, 2006-2025. Chronic Dis Can. 2011 Mar;31(2):71-8. 

1. Japandeep Sethi, BSc, Justin P Gawaziuk, MSc, Nora Cristall, MSW, PhD, Sarvesh Logsetty, MD, The Relationship Between Income and Burn Incidence in Winnipeg, Manitoba, Canada: A Population Health Study, Journal of Burn Care & Research, Volume 39, Issue 5, September/October 2018, Pages 645–651

2. Logsetty S, Shamlou A, Gawaziuk JP, March J, Doupe M, Chateau D, Hoppensack M, Khan S, Medved M, Leslie WD, Enns MW, Stein MB, Asmundson GJ, Sareen J. Mental health outcomes of burn: A longitudinal population-based study of adults hospitalized for burns. Burns. 2016 Jun;42(4):738-44.

3. Stone J, Gawaziuk JP, Khan S, Chateau D, Bolton JM, Sareen J, Enns J, Doupe M, Brownell M, Logsetty S. Outcomes in Adult Survivors of Childhood Burn Injuries as Compared with Matched Controls. J Burn Care Res. 2016 Mar-Apr;37(2):e166-73.